Dr. Evelyn M. Brosnan, MD

Dr. Brosnan practices at Kaiser Foundation Health Plan of the Northwest in Portland, Oregon.

Dr. Brosnan's NPI, 1497098941, was assigned on April 3, 2013. Dr. Brosnan graduated from University of Colorado School of Medicine, Denver in 2013. Dr. Brosnan holds Oregon license MD192507.

Dr. Brosnan's primary practice is Kaiser Foundation Health Plan of the Northwest, at 500 NE Multnomah St, Portland, OR 97232 in Multnomah County. The practice phone is (503) 813-2440.

Dr. Brosnan's primary practice is Kaiser Foundation Health Plan of the Northwest in Portland, Oregon. Dr. Brosnan is also affiliated with Providence St. Vincent Medical Center. The medical group on file is Kaiser Permanente Northwest. Dmand AI also links Dr. Brosnan to 4 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brosnan practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Brosnan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Brosnan is licensed in Oregon.

CMS data shows 543 Medicare services from Dr. Brosnan across 6 procedure codes in 2024, for 77 Medicare patients. Medicare paid $32,381 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 77 Medicare patients who saw Dr. Brosnan in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have cancer, and 71% have high blood pressure. 23% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brosnan's median patient age at 74, with 65% women.

In 2024, Dr. Brosnan wrote 773 Medicare Part D claims for 110 patients. 75% of them were for generic drugs. CMS names the drug for 648 of them, across 21 drugs with 11 or more claims each, at $1,611,589 in total drug cost. In 2023, CMS named 658 claims across 20 drugs.

Dr. Brosnan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Brosnan, published from 2013 to 2022. The most frequent topics are Pyrazoles, Adenocarcinoma and Anaplastic Lymphoma Kinase. Dr. Brosnan's most frequent co-authors are Michel B. Chonchol, MD, Rehan Saeed Ahmad, MD and Eric Daniel Bernstein, MD.

Dmand AI links Dr. Brosnan to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Neoplasm Metastasis and Breast Diseases. Providence Health & Services sponsors the most, 2.

CMS Open Payments shows 6 general payments to Dr. Brosnan from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $156.

Dr. Brosnan graduated from University of Colorado School of Medicine, Denver in 2013.